StockNews.AI
DNA
StockNews.AI
19 days

Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation

1. Ginkgo Bioworks will host a Q&A presentation on August 7, 2025. 2. The focus will be on second-quarter performance for Q2 2025. 3. Ginkgo provides tools for cell programming and biosecurity. 4. Their R&D solutions include protein engineering and nucleic acid design. 5. Their biosecurity efforts address various biological threats globally.

Earnings
-7.53%Current Return
VS
-1.88%S&P 500
$12.8807/31 08:14 AM EDTEvent Start
$11.9108/01 02:41 PM EDTLatest Updated
5m saved
Insight
Article

FAQ

Why Bullish?

Ginkgo's upcoming presentation may indicate strong business performance and investor confidence, akin to previous successful quarter presentations that positively impacted stock value.

How important is it?

The presentation reflects Ginkgo's strategic direction and performance, which directly affects investor sentiment and stock price, particularly with innovation in biotech.

Why Short Term?

The focus on second-quarter performance will influence stock movement soon, similar to past quarterly reports that led to immediate market reactions.

Related Companies

AMGNREGNCRSPEDIT
Presentation and Q&A session scheduled for post-market on Thursday, August 7, 2025 , /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the second quarter ended June 30, 2025, on Thursday, August 7, 2025, beginning at 5:30 p.m. ET. The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available. To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to [email protected]. About Ginkgo BioworksGinkgo Bioworks builds the tools that make biology easier to engineer for everyone. Ginkgo R&D Solutions delivers customizable R&D packages—such as protein engineering, nucleic acid design, and cell-free systems—giving partners a comprehensive way to accelerate innovation across therapeutics, diagnostics, & manufacturing. Ginkgo Automation sells modular, integrated laboratory automation so scientists can spend their days planning and analyzing experiments rather than pipetting in the lab. Ginkgo Datapoints uses Ginkgo's in-house automation to generate the large lab data sets to power your AI models. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn. Ginkgo Bioworks Contacts: INVESTOR CONTACT: [email protected] MEDIA CONTACT: [email protected] SOURCE Ginkgo Bioworks WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News